Microbiome Comparison Profile of Normal Skin and Acne Vulgaris Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

144 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-17

Study Completion Date

2023-05-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to compare the profile of the microbiome on normal skin and acne vulgaris patients. A cross sectional study with 144 samples, male or female between 18-40 years old, from January to May 2023.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Measurement of Serum microRNA in Acne Vulgaris Patient

NCT05885217

Acne Vulgaris

UNKNOWN

The Relationship Between Microbioma Balance and Acne Vulgaris as a New Acne Treatment

NCT06925386

Acne Vulgaris

NOT_YET_RECRUITING PHASE2

Comparison of Malassezia Spp Proportions in Inflammatory and Non Inflammatory Facial Acne Vulgaris Lesions

NCT04367584

Acne Vulgaris

COMPLETED

A Pilot Study to Explore the Role of Gut Flora in Acne

NCT04214483

Acne Acne Vulgaris Acne Keloidalis +16 more

WITHDRAWN

A Study of the Safety, Engraftment, and Action of NB01 in Adults With Moderate Acne

NCT03450369

Acne Vulgaris

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Recently, research on the role of the microbiome in the process of acne vulgaris has continued to grow. Seeing the important role of the microbiome in maintaining the balance of skin health, this study aims to compare the profile of the microbiome on normal skin and on acne vulgaris patients, in order to gain a deeper understanding the role of the microbiome in acne vulgaris and also to compare skin microbiome features in various degrees of acne vulgaris severity. This research is an observational study with a cross sectional design. Subject selected by consecutive sampling, with total 144 samples consists of males and females age 18-40.

There will be two visits in this research. The first visit, for screening patients with requests for informed consent, giving facial soap, screening for inclusion and exclusion criteria, screening for facial skin complaints and facial care habits, collecting data on patient demographics and medical history, physical examination, sebumeter examination to measure sebum levels on facial skin, and taking clinical photos for documentation. The second visit is collecting microbiome data which will be taking in 1 to 2 weeks after the first visit. Using swab method to take microbiome samples, after that, there will be DNA extraction, amplification and sequencing were carried out on the sample and the Shannon Index will be calculated. Then, the data will be tabulated and analyzed according to the hypothesis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acne Vulgaris

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal Skin

No interventions assigned to this group

Mild Acne Vulgaris

No interventions assigned to this group

Moderate Acne Vulgaris

No interventions assigned to this group

Severe Acne Vulgaris

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female, 18-40 years old
* Normal individuals who have not had acne vulgaris in the last 5 years and have never had moderate or severe acne vulgaris
* Patients with mild, moderate, or severe acne vulgaris who have acne vulgaris lesions that are representative of the grade and equally distributed in all facial regions (forehead, cheeks, and chin)
* Patients agree to participate in the study and sign informed consent

Exclusion Criteria

* Pregnancy
* Diagnosed with other inflammatory or infectious diseases on the face
* Diagnosed with psoriasis or have atopic
* Diagnosed with primary or secondary immunodeficiency disease
* Patients with a history of laser therapy or facial dermabrasion within the past month
* Using oral or systemic antibiotics, anti-inflammatory, retinoids or hormone therapy in the last 1 month
* Using topical retinoid therapy, antibiotics, benzoyl peroxide, or other topical products in the last 2 weeks
* Acne conglobata

Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr.dr.Irma Bernadette, SpKK (K)

Prof. Dr. dr. Irma Bernadette S. Sitohang, SpKK - Head of Cosmetic Dermatology Division, Department of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia, dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia

Responsibility Role SPONSOR_INVESTIGATOR